EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study

Mustafa Şahin iD, Tufan Arslanca

International Journal of Women's Health · 2026-04 · Volume 18 · 1-14

DOI: 10.2147/ijwh.s594002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Women's Health, 2026-04. Verfasst von Mustafa Şahin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Konya City Hospital, Konya, Türkiye. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigates the potential impact of coronavirus disease 2019 (COVID-19) vaccination on the persistence of high-risk human papillomavirus (HR-HPV) and cervical cytopathological outcomes. While targeted vaccines like the HPV vaccine are established modifiers of viral clearance, the influence of non-targeted systemic platforms and whether they exert any "bystander" immune effect on HR-HPV remains under-explored.

Methods

In this retrospective study, clinical data were obtained from the colposcopy database and electronic health records of a tertiary care center in Turkey. A total of 1,435 HR-HPV positive women were analyzed over a mean follow-up period of 18.4 months. Participants were divided into COVID-19 vaccinated (n=723) and unvaccinated (n=712) groups. To isolate the specific impact of systemic immunization, individuals with prior COVID-19 infection, HPV vaccination, or cervical surgical procedures were excluded. Statistical analyses were performed using SPSS v22.0. HR-HPV persistence and cytological progression were compared using Pearson's Chi-square and Fisher's exact tests. Selection bias was ruled out via attrition analysis, and vaccination influence was assessed using multivariate logistic regression adjusted for age and follow-up duration.

Results

At the 18.4-month follow-up, the estimated prevalence of HR-HPV persistence showed no statistically significant difference between the COVID-19 vaccinated and unvaccinated groups (p=0.600; 95% CI: -2.91 to 5.11). Persistence status for highly oncogenic genotypes appeared comparable for HPV-16 (p=0.922; 95% CI: -9.0 to 10.0) and HPV-18 (p=0.927; 95% CI: -15.8 to 14.4). Multivariable logistic regression analysis confirmed that vaccination status (aOR=1.108; 95% CI: 0.75-1.63) was not an independent risk factor for persistence. Furthermore, the prevalence of cervical precancerous lesions, including abnormal cytology (p=0.095) and biopsy-confirmed findings such as LSIL and HSIL (p=0.315; 95% CI: -8.8 to 19.4), remained similar across both cohorts. While HR-HPV related cervical cancers remain a significant global burden with high estimated incidence, our data demonstrated that systemic COVID-19 vaccination does not increase the risk of cytological progression or interfere with the natural clearance of high-risk genotypes.

Conclusion

Systemic COVID-19 vaccination does not appear to influence the natural history of HR-HPV. Our findings suggest a state of immune compartmentalization where systemic immunization remains independent of localized cervical dynamics. Unlike targeted mucosal vaccines, these platforms maintain a neutral effect on viral clearance.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 vaccinationHPV persistencecervical cytologyhigh risk HPV in womenmucosal immunity

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Konya City Hospital, Konya, Türkiye.
  • Department of Gynecologic Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye.

ORCID-Profile: Mustafa Şahin

Zitieren

APA

Şahin, M., & Arslanca, T. (2026). The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study. International Journal of Women's Health, Volume 18, 1-14. https://doi.org/10.2147/ijwh.s594002

Vancouver

Şahin M, Arslanca T. The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study. International Journal of Women's Health. 2026;Volume 18:1-14. doi:10.2147/ijwh.s594002

BibTeX
@article{ahin2026,
  author = {Şahin, Mustafa and Arslanca, Tufan},
  title = {The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study},
  journal = {International Journal of Women's Health},
  year = {2026},
  volume = {Volume 18},
  pages = {1--14},
  doi = {10.2147/ijwh.s594002}
}
Kostenlos starten →